Poland struggles with penury and a corrupt health system
This article was originally published in Clinica
The Polish healthcare system is still in a state of upheaval and suppliers that are new to the market should tread carefully, given that the system is seriously in debt - to the tune of $2bn - and corruption and bribery are still rife.
You may also be interested in...
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.
Johnson & Johnson believes personalization via digital holds the key to smoking cessation success as it launches in the UK its app-supported Nicorette QuickMist SmartTrack product.